These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 24092936)

  • 1. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody.
    Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS
    J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-cyclooctene tag with improved properties for tumor pretargeting with the diels-alder reaction.
    Rossin R; van Duijnhoven SM; Läppchen T; van den Bosch SM; Robillard MS
    Mol Pharm; 2014 Sep; 11(9):3090-6. PubMed ID: 25077373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabody Pretargeting with Click Chemistry In Vivo.
    van Duijnhoven SM; Rossin R; van den Bosch SM; Wheatcroft MP; Hudson PJ; Robillard MS
    J Nucl Med; 2015 Sep; 56(9):1422-8. PubMed ID: 26159589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
    Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
    MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward the Optimization of Click-Mediated Pretargeted Radioimmunotherapy.
    Membreno R; Keinänen OM; Cook BE; Tully KM; Fung KC; Lewis JS; Zeglis BM
    Mol Pharm; 2019 May; 16(5):2259-2263. PubMed ID: 30912951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DOTA-tetrazine probes with modified linkers for tumor pretargeting.
    Läppchen T; Rossin R; van Mourik TR; Gruntz G; Hoeben FJM; Versteegen RM; Janssen HM; Lub J; Robillard MS
    Nucl Med Biol; 2017 Dec; 55():19-26. PubMed ID: 29028502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting.
    Altai M; Perols A; Tsourma M; Mitran B; Honarvar H; Robillard M; Rossin R; ten Hoeve W; Lubberink M; Orlova A; Karlström AE; Tolmachev V
    J Nucl Med; 2016 Mar; 57(3):431-6. PubMed ID: 26659353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal-Free Cycloaddition Chemistry Driven Pretargeted Radioimmunotherapy Using α-Particle Radiation.
    Shah MA; Zhang X; Rossin R; Robillard MS; Fisher DR; Bueltmann T; Hoeben FJM; Quinn TP
    Bioconjug Chem; 2017 Dec; 28(12):3007-3015. PubMed ID: 29129050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Radionuclide Theranostic Pretargeting.
    Keinänen O; Brennan JM; Membreno R; Fung K; Gangangari K; Dayts EJ; Williams CJ; Zeglis BM
    Mol Pharm; 2019 Oct; 16(10):4416-4421. PubMed ID: 31483993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry.
    Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS
    J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly reactive trans-cyclooctene tags with improved stability for Diels-Alder chemistry in living systems.
    Rossin R; van den Bosch SM; Ten Hoeve W; Carvelli M; Versteegen RM; Lub J; Robillard MS
    Bioconjug Chem; 2013 Jul; 24(7):1210-7. PubMed ID: 23725393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of IEDDA bioorthogonal system: Efficient process to improve trans-cyclooctene/tetrazine interaction.
    Béquignat JB; Ty N; Rondon A; Taiariol L; Degoul F; Canitrot D; Quintana M; Navarro-Teulon I; Miot-Noirault E; Boucheix C; Chezal JM; Moreau E
    Eur J Med Chem; 2020 Oct; 203():112574. PubMed ID: 32683167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.
    Meyer JP; Tully KM; Jackson J; Dilling TR; Reiner T; Lewis JS
    Bioconjug Chem; 2018 Feb; 29(2):538-545. PubMed ID: 29378403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IEDDA: An Attractive Bioorthogonal Reaction for Biomedical Applications.
    Handula M; Chen KT; Seimbille Y
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging.
    Reiner T; Lewis JS; Zeglis BM
    J Vis Exp; 2015 Feb; (96):e52335. PubMed ID: 25742199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry.
    Ferreira VFC; Oliveira BL; D'Onofrio A; Farinha CM; Gano L; Paulo A; Bernardes GJL; Mendes F
    Bioconjug Chem; 2021 Jan; 32(1):121-132. PubMed ID: 33295756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry.
    Houghton JL; Membreno R; Abdel-Atti D; Cunanan KM; Carlin S; Scholz WW; Zanzonico PB; Lewis JS; Zeglis BM
    Mol Cancer Ther; 2017 Jan; 16(1):124-133. PubMed ID: 28062708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    Houghton JL; Zeglis BM; Abdel-Atti D; Sawada R; Scholz WW; Lewis JS
    J Nucl Med; 2016 Mar; 57(3):453-9. PubMed ID: 26471693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
    Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
    Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.